Cochlear Valuation
| OC5 Stock | EUR 120.00 4.00 3.23% |
At this time, the firm appears to be overvalued. Cochlear Limited shows a prevailing Real Value of €100.8 per share. The current price of the firm is €120.0. Our model approximates the value of Cochlear Limited from analyzing the firm fundamentals such as return on equity of 0.18, and Profit Margin of 0.15 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 7.0071 | Enterprise Value 7.8 B | Enterprise Value Ebitda 23.1531 | Price Sales 3.3755 | Forward PE 30.4878 |
Overvalued
Today
Please note that Cochlear's price fluctuation is very steady at this time. Calculation of the real value of Cochlear Limited is based on 3 months time horizon. Increasing Cochlear's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cochlear stock is determined by what a typical buyer is willing to pay for full or partial control of Cochlear Limited. Since Cochlear is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cochlear Stock. However, Cochlear's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 120.0 | Real 100.8 | Hype 120.76 |
The real value of Cochlear Stock, also known as its intrinsic value, is the underlying worth of Cochlear Limited Company, which is reflected in its stock price. It is based on Cochlear's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cochlear's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cochlear Limited helps investors to forecast how Cochlear stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cochlear more accurately as focusing exclusively on Cochlear's fundamentals will not take into account other important factors: Cochlear Cash |
|
About Cochlear Valuation
The stock valuation mechanism determines Cochlear's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cochlear. We calculate exposure to Cochlear's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cochlear's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2 B | 1.3 B |
Cochlear Quarterly Retained Earnings |
|
Complementary Tools for Cochlear Stock analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |